CVS (CVS) stock
Last close $80.84 on 2026-11-20 (+1.00%) · Sector: Healthcare
CVS Health is a large American healthcare company. It owns CVS Pharmacy, a chain of retail drugstores, and CVS Caremark, a pharmacy benefits manager that manages prescription drug coverage for insurers and employers. It makes money from store sales, filling prescriptions, and fees for running drug benefit plans.
CVS is a very large business, with latest quarterly revenue of $108.4 billion, but its profit margins are thin, so each dollar of sales keeps only a few cents. Over the past year the stock returned 3.8%, slightly more than the S&P 500's 3.2%. It is still well below its recent high and below both its 50-day and 200-day average prices. Insider activity was mixed: one director sold about $317.5 million of stock in May, and a senior executive made a small purchase in November.
Key numbers
- Market cap: $104.4B
- Revenue (last 12 months): $420.62B
- Revenue growth: +6.7%
- Gross margin: 44.2%
- Operating margin: 3.6%
- P/S: 0.2
- Debt to equity: 0.79
- Current ratio: 0.85
Quality score
Overall 31/100 · growth 35 · profitability 24 · financial health 35 · value None
Performance and risk
1-year return +3.8% vs S&P 500 +3.1% · volatility 34.6% (S&P 500 14.2%) · largest drop -27.7% · beta -0.01
Stock move the day after earnings
- 2026-02-10: -0.1%
- 2026-05-06: +7.6%
- 2026-08-05: -5.1%
- 2026-11-04: -12.5%
Insider trades (12 months)
Bought $2.0M · sold $323.7M
CVS stock research · CVS options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.